search
Back to results

IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair

Primary Purpose

Laceration of Skin

Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Ketamine
Midazolam and fentanyl
Sponsored by
William Beaumont Hospitals
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Laceration of Skin focused on measuring Pediatric, analgesia, pain control, sedation, intranasal ketamine, intranasal midazolam, intranasal fentanyl

Eligibility Criteria

6 Months - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pediatric patients 6 months to 10 years who required laceration repair in the pediatric emergency center.
  • Laceration should be less than 5 cm long, require 2 or more sutures and no consult subspeciality consult for repair.
  • Topical anesthetic (lidocaine-epinephrine-tetracaine topical solution/XAP) will be applied to all lacerations for 20 minutes duration before giving the intranasal medications.

Exclusion Criteria:

  • Age < 6 months
  • Documented allergy or adverse effect to ketamine, midazolam or fentanyl
  • Epistaxis
  • Partial upper airway obstruction
  • Oxygen requirement via nasal cannula
  • Acute mental status changes (e.g. obtunded or somnolent)
  • Documented increased intracranial pressure or increased ocular pressure
  • Documented porphyria
  • Previously involved in the study
  • Parent or patient refusal
  • Acutely compromised vitals (hypotension, desaturations, respiratory distress)
  • Any known heart disease
  • If any previous opioid use for analgesia during the visit
  • Need for staples
  • Scalp wounds
  • General trauma requiring additional sedation
  • Patients who received pain medications (acetaminophen or ibuprofen) before laceration repair

Sites / Locations

  • Beaumont Hospital - Royal Oak

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

IN ketamine

IN midazolam and fentanyl

Arm Description

Intranasal ketamine 3mg/kg (max 100 mg) + saline 0.03 ml/kg (max 2ml)

Intranasal midazolam 0.3 mg/kg (max 10 mg) + fentanyl 1.5mcg/kg (max 100 mcg)

Outcomes

Primary Outcome Measures

Sedation Score
The primary outcome variable is the maximum sedation score as measured by the University of Michigan Sedation Scale. This scale consists of an ordinal scale from 0 being awake and alert and 4 being unarousable. Medians will be calculated for each group.
Proportion of Children With Maximum Sedation Score
The proportion of children who receive a maximum sedation score of either 1 or 2 (without distinguishing between those values)

Secondary Outcome Measures

Pain Scores During Laceration Repair
The effect of IN ketamine vs IN midazolam + IN fentanyl on pain scores during laceration repair using either Face, Legs, Activity, Cry, Consolability (FLACC) Scale or Faces Scale pain scale depending for patient age, each a Likert scale from 0 being no pain to 10 being worst pain, median scores for each group
Nurse and Physician Satisfaction
Nurse and physician satisfaction will be assessed by a survey which will be filled in the end of the sedation. Response to overall experience question score on Likert scale where 1 is poor and 5 is Excellent. Proportion of responders giving answers of 4 or 5 will be calculated.
Rates of Failure
Rates of failure to repair laceration due to agitation or intolerable pain with the switch to intravenous medications will be compared between two groups. Percentage failure will be reported.
Change in Vitals
Proportion of children who have any significant change in vitals during analgosedation (any desaturation - Oxygen saturation < 90, and hypotension per age-related norms) will be compared between the two groups.

Full Information

First Posted
May 5, 2018
Last Updated
July 29, 2021
Sponsor
William Beaumont Hospitals
search

1. Study Identification

Unique Protocol Identification Number
NCT03528512
Brief Title
IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
Official Title
Comparison of Sedation, Pain, and Care Provider Satisfaction Between the Use of Intranasal Ketamine Versus Intranasal Midazolam and Fentanyl During Laceration Repair
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Terminated
Why Stopped
Staffing for study was eliminated
Study Start Date
September 4, 2018 (Actual)
Primary Completion Date
February 6, 2019 (Actual)
Study Completion Date
February 6, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
William Beaumont Hospitals

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Often, repair of the cuts (laceration repair) proves to be traumatic for the children and the parents. Nasal spray (Intranasal/IN) approaches for procedural pain reduction, such as during dental work, have been demonstrated to make drug administration painless and well tolerated. We are comparing IN ketamine to IN midazolam and fentanyl for pain and reducing anxiety during repair of cuts in children.
Detailed Description
Children frequently present to pediatric emergency center (PEC) with cuts of different body parts. Often, repair of the cuts (laceration repair) proves to be traumatic for the children and the parents alike. Ideally, repair of the cuts should be as painless and free from anxiety as possible. To work towards this goal, different analgesic (pain drugs) and sedative ( to calm patients down) management strategies use intravenous (into the vein), intramuscular ( into the muscle) and, more recently, intranasal (into the nostrils) routes. Unfortunately, intravenous access is hard to establish and may be painful for the child. The intramuscular route is often similarly painful. Due to the rich blood supply and large surface area of the nasal vestibule, intranasally (IN) administered medications are highly absorbed. IN approaches for procedural pain reduction, such as during dental work, have been demonstrated to make drug administration painless and well tolerated, making it an attractive potential alternative to commonly used intravenous and intramuscular approaches. In several small research studies, high doses of intranasal ketamine (9 mg/kg) produce adequate sedation during laceration repair with minimal side effects. A recent study compared IN ketamine, midazolam, fentanyl or combination of these drugs for pain management and urgent analgesia sedation, and demonstrated that they are effective and safe, reporting that ~60% of study participants sustained mild to moderate sedation. Unfortunately, there are not enough studies done to evaluate the sedation effect of IN ketamine for laceration repair. Small studies (Tsze and Nemeth) showed that IN ketamine is an effective alternative but no studies are done to compare combination IN midazolam and fentanyl to IN ketamine. Our null hypothesis is that there is no difference in sedation scores during laceration repair when comparing the use of IN ketamine to IN midazolam and IN fentanyl. We will recruit a total of 30 pediatric patients (6 months - 10 y age) in a randomized double-blinded pilot study of IN ketamine alone or combined IN midazolam and IN fentanyl for laceration repair, comparing levels of pain and sedation scores using validated pediatric metrics as the primary outcomes. In addition, we will assess comparative nurse and physician satisfaction in each of these two groups. Understanding the relative effectiveness of these two approaches will help us identify a safe, effective, and easily administrable method to manage pain and anxiety, thereby, improving patient experience and outcomes during the often traumatic laceration repair procedure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laceration of Skin
Keywords
Pediatric, analgesia, pain control, sedation, intranasal ketamine, intranasal midazolam, intranasal fentanyl

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Randomized double blinded control trial
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
A randomization list created by an online randomization tool will be used to assign participants to a treatment arm (in random blocks of 4, 6, and 8). As participants are enrolled in the study, they will be assigned to the next available sequential treatment arm.
Allocation
Randomized
Enrollment
5 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IN ketamine
Arm Type
Experimental
Arm Description
Intranasal ketamine 3mg/kg (max 100 mg) + saline 0.03 ml/kg (max 2ml)
Arm Title
IN midazolam and fentanyl
Arm Type
Active Comparator
Arm Description
Intranasal midazolam 0.3 mg/kg (max 10 mg) + fentanyl 1.5mcg/kg (max 100 mcg)
Intervention Type
Drug
Intervention Name(s)
Ketamine
Intervention Description
Intranasal ketamine 3mg/kg (max 100 mg) + saline 0.03 ml/kg (max 2ml)
Intervention Type
Drug
Intervention Name(s)
Midazolam and fentanyl
Intervention Description
Intranasal midazolam 0.3 mg/kg (max 10 mg) + fentanyl 1.5mcg/kg (max 100 mcg)
Primary Outcome Measure Information:
Title
Sedation Score
Description
The primary outcome variable is the maximum sedation score as measured by the University of Michigan Sedation Scale. This scale consists of an ordinal scale from 0 being awake and alert and 4 being unarousable. Medians will be calculated for each group.
Time Frame
up to 30 minutes
Title
Proportion of Children With Maximum Sedation Score
Description
The proportion of children who receive a maximum sedation score of either 1 or 2 (without distinguishing between those values)
Time Frame
Up to 30 minutes
Secondary Outcome Measure Information:
Title
Pain Scores During Laceration Repair
Description
The effect of IN ketamine vs IN midazolam + IN fentanyl on pain scores during laceration repair using either Face, Legs, Activity, Cry, Consolability (FLACC) Scale or Faces Scale pain scale depending for patient age, each a Likert scale from 0 being no pain to 10 being worst pain, median scores for each group
Time Frame
Up to 30 minutes
Title
Nurse and Physician Satisfaction
Description
Nurse and physician satisfaction will be assessed by a survey which will be filled in the end of the sedation. Response to overall experience question score on Likert scale where 1 is poor and 5 is Excellent. Proportion of responders giving answers of 4 or 5 will be calculated.
Time Frame
Up to 30 minutes
Title
Rates of Failure
Description
Rates of failure to repair laceration due to agitation or intolerable pain with the switch to intravenous medications will be compared between two groups. Percentage failure will be reported.
Time Frame
Up to 30 minutes
Title
Change in Vitals
Description
Proportion of children who have any significant change in vitals during analgosedation (any desaturation - Oxygen saturation < 90, and hypotension per age-related norms) will be compared between the two groups.
Time Frame
up to 30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pediatric patients 6 months to 10 years who required laceration repair in the pediatric emergency center. Laceration should be less than 5 cm long, require 2 or more sutures and no consult subspeciality consult for repair. Topical anesthetic (lidocaine-epinephrine-tetracaine topical solution/XAP) will be applied to all lacerations for 20 minutes duration before giving the intranasal medications. Exclusion Criteria: Age < 6 months Documented allergy or adverse effect to ketamine, midazolam or fentanyl Epistaxis Partial upper airway obstruction Oxygen requirement via nasal cannula Acute mental status changes (e.g. obtunded or somnolent) Documented increased intracranial pressure or increased ocular pressure Documented porphyria Previously involved in the study Parent or patient refusal Acutely compromised vitals (hypotension, desaturations, respiratory distress) Any known heart disease If any previous opioid use for analgesia during the visit Need for staples Scalp wounds General trauma requiring additional sedation Patients who received pain medications (acetaminophen or ibuprofen) before laceration repair
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kelly Levasseur, DO
Organizational Affiliation
William Beaumont Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beaumont Hospital - Royal Oak
City
Royal Oak
State/Province
Michigan
ZIP/Postal Code
48073
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair

We'll reach out to this number within 24 hrs